Short-term results of endovascular intervention with bifurcation graft in elective infrarenal abdominal aortic aneurysm
Hakkı Zafer İşcan, Ertekin Utku Unal, Bahadır Aytekin, Mehmet Cahit Sarıcaoğlu, Onur Karahasanoğlu, Erman Kiriş, Boğaçhan Akkaya, Veysel Başar, Mehmet Hamdi Özbek, İsa Civelek, Ufuk Tütün
DOI: 10.9739/tjvs.2018.118 · Page: 078-084 · 78 Views · 6 Downloads · 3 Citations
Abstract
Patients and methods: Between January 2012 and January 2017, data of 63 consecutive and elective patients (60 males, 3 females; mean age: 68.2±7.2 years; range, 57 to 87 years) with the diagnosis of an infrarenal abdominal aortic aneurysm (IAAA) who were treated with AFX® (Endologix, Inc., Irvine, CA, USA - Bifurcated Endograft System) graft were retrospectively analyzed. Data of the patients were evaluated in three stages: preoperatively, intraoperatively, and postoperatively.
Results: Hypertension (63.5%) and coronary artery disease (57.1%) were the most common comorbidities and 34 patients (53.9%) underwent an intervention under local anesthesia. The mean duration of the procedure was 131.3±25.4 min, the duration of the scopy was 17.8±4.0 min, and the amount of opaque used was 67.0±16.9 mL. No mortality, renal complications, and myocardial infarction were observed in any of the patients in the early postoperative period. The mean length of hospital stay was 2.3±1.4 days. No conversion to open surgery was needed in any patients. The technical success rate of the procedure was found to be 100%.
Conclusion: The results of our study show that the Endologix AFX® graft is effective and safe in the short-term.
Keywords : Bifurcation graft; endoleak; reintervention